The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution’s experience-Reference-Cited by-同舟云学术

The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution’s experience

Published:2012-07-20 Issue:11 Volume:14 Page:835-841
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Bosch-Barrera Joaquim,García-Franco Carlos,Guillén-Grima Francisco,Moreno-Jiménez Marta,López-Picazo José María,Gúrpide Alfonso,Pérez-Gracia José Luis,Aristu Javier,Torre Wenceslao,García-Foncillas Jesús,Gil-Bazo Ignacio

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-012-0874-3.pdf

Reference24 articles.

1. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781

2. Jemal A, Siegel R, Xu J et al (2010) Cancer Statistics, 2010. CA Cancer J Clin 60:277–300

3. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717

4. Shields TW (1990) The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. A commentary. J Thorac Cardiovasc Surg 99:48–53

5. Rosell R, Gomez-Codina J, Camps C et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153–158

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study;Cancer Immunology, Immunotherapy;2024-05-07

2. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy;Journal of Cancer Research and Clinical Oncology;2023-07-05

3. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.;2023-05-30

4. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis;BMC Cancer;2018-11-06

5. Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review;OncoTargets and Therapy;2016-02